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Abstract
Background: In the fields of life sciences, so-called designed studies are used for studying complex
biological systems. The data derived from these studies comply with a study design aimed at
generating relevant information while diminishing unwanted variation (noise). Knowledge about the
study design can be used to decompose the total data into data blocks that are associated with
specific effects. Subsequent statistical analysis can be improved by this decomposition if these are
applied on selected combinations of effects.
Results:  The benefit of this approach was demonstrated with an analysis that combines
multivariate PLS (Partial Least Squares) regression with data decomposition from ANOVA
(Analysis of Variance): ANOVA-PLS. As a case, a nutritional intervention study is used on
Apoliprotein E3-Leiden (APOE3Leiden) transgenic mice to study the relation between liver
lipidomics and a plasma inflammation marker, Serum Amyloid A. The ANOVA-PLS performance
was compared to PLS regression on the non-decomposed data with respect to the quality of the
modelled relation, model reliability, and interpretability.
Conclusion: It was shown that ANOVA-PLS leads to a better statistical model that is more
reliable and better interpretable compared to standard PLS analysis. From a following biological
interpretation, more relevant metabolites were derived from the model. The concept of combining
data composition with a subsequent statistical analysis, as in ANOVA-PLS, is however not limited
to PLS regression in metabolomics but can be applied for many statistical methods and many
different types of data.
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Background
In the field of life sciences, many studies are performed
where the influence of external stimuli is investigated on
the organism's gene transcription, protein expression, and
metabolism ("systems biology"). Examples of these stim-
uli are the administration of drugs or a specific diet. These
studies aim at understanding how changes in stimuli can
affect an individual's genes and health but also at finding
biomarkers in tissues or fluids that predict or influence the
onset of a disease, or assesses its incidence or patho-phys-
iological behaviour. Measurement of such a marker
allows quantification of the extent to which an individual
is susceptible to the development of disease.
Successfully analyzing life science studies and so-called
omics data (i.e. transcriptomics, proteomics, metabo-
lomics) requires appropriate bioinformatics tools and the
conceptual frameworks for analysis and interpretation of
large amounts of data generated.
In general, the process from conducting a study to obtain-
ing systems biology data, and deriving molecular insight
from that is a delicate one. It requires a well-thought
workflow that translates the research hypothesis to a sta-
tistical study design, facilitates the performance of vali-
dated sample preparation, data acquisition, and the
interpretation of statistical results (see also [1]). Another
point of attention with this kind of data is that small
changes in the stimuli can trigger multiple changes in gene
expression, protein and metabolite levels. These changes
are usually very small compared to the biological back-
ground variation in the data which means that the statis-
tical power of the analysis is low. An additional difficulty
in data interpretation is that the data are usually struc-
tured. Descending from a biological research question,
the data often contain underlying factors such as time,
dose, diet, groups, or combinations that correspond to
different sources of variation. It can be anticipated that if
this data structure is taken into account, the data analysis
becomes more focused on relevant sources of variation
and therefore has more power. However, most of the cur-
rently used statistical approaches simply ignore the struc-
ture of the data.
Analysis of Variance (ANOVA) is an obvious method to
analyse the data structure by decomposing the total data
into different sources of variance. ANOVA is a so-called
univariate method which means that it analyses one varia-
ble at a time. As such, it has been used for the correction
or analysis of high dimensional gene expression and
metabolomic data [2-4]. In contrast, it was also combined
with Principal Component Analysis (PCA) and Simulta-
neous Component Analysis (SCA) to allow a multivariate
data analysis while taking the underlying study design
into account [5-8]. However, in these approaches,
ANOVA was not combined with a supervised analysis
such as regression which is a very useful technique in life
science studies.
A regression analysis is generally used to determine the
relationship between two types of data (e.g. omics data
and a phenotype) obtained from the study subjects. In
these studies, the aim of regression is not to predict the
value of the phenotype but to derive reliable and validated
relationships that can be studied further to select and
interpret those genes, proteins, or metabolites that are
most important with respect to the phenotype. Therefore,
this paper aims to show how the quality and interpretabil-
ity of statistical regression models can be improved by
explicitly using the data structure. In the past for the anal-
ysis of a chemical process, a like-wise approach was per-
formed by [9], however limited to only within-run and
between-run variance.
As a case study, Liquid Chromatography Mass Spectrome-
try (LC-MS) liver lipidomics data have been used. These
data are a part of a large-scale nutritional intervention sur-
vey performed in Apolipoprotein E3-Leiden
(ApoE3Leiden, [10]) transgenic mice. In these mice, dur-
ing the early time points, the time resolved development
of diet-induced obesity and insulin resistance was investi-
gated. As a phenotype, the hepatic inflammation marker
Serum Amyloid A (SAA) was measured in blood plasma of
these mice. The final data set consists of 61 mice for which
40 lipids and 19 free fatty acids were measured (i.e. 59 var-
iables) as well as 1 clinical inflammation marker. Inflam-
mation is believed to play an important role in the
development of diet related diseases such as obesity, dia-
betes type II, and atherosclerosis [11] together with the
liver as key organ and lipids and free fatty acids as impor-
tant inflammation related metabolites. For optimal data
interpretation, based on the underlying study design, data
decomposition by ANOVA is combined with Partial Least
Squares (PLS) regression analysis to define the relation-
ship between LC-MS lipidomics and the inflammation
marker, SAA. This combination is called ANOVA-PLS. For
comparison, standard data analysis was also performed
using PLS on the total data. Our findings demonstrate the
advantage of incorporating the study design in the data
evaluation.
Methods
Statistical theory
The principles of ANOVA have been used to separate the
different sources of variation of the data based on the
underlying study design. The resulting independent data
blocks and their combinations can be analysed in various
ways including explorative analysis (such as ANOVA-SCA:
ASCA) or regression analysis (as in ANOVA-PLS). Before
explaining ANOVA-PLS, this section briefly describes the
ideas behind ANOVA, SCA, and ASCA.BMC Bioinformatics 2009, 10:52 http://www.biomedcentral.com/1471-2105/10/52
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Analysis of Variance
Classical ANOVA techniques can be used to distinguish
different sources of variation [12]. The aim of ANOVA is
to separate the sources of variation and to assign them to
specific factors. This is done by splitting the variations
into orthogonal and independent parts. In this paper, an
ANOVA model will be used to describe two main factors
(time, diet) and their interaction (time × diet):
xkci = μ + αk + βc + (αβ)kc + εkci (1)
where xkc is the data observed for the sample i on levels k
and c, μ is the overall offset, αk is the model parameter for
the factor time at level k, βc is the parameter for diet at level
c, (αβ)kc is the parameter of time × diet interaction, and εkci
the residual.
If the parameters of this model are calculated under the
proper constraints, the model uniquely separates the total
data into orthogonal (independent) data blocks that rep-
resent the known factors from the design. The remaining
part of the data equals the difference between the sum of
the known data blocks and the total data. That part is
called the residual part and contains sources of variation
that cannot be attributed to a known factor. These sources
of variation can originate from unknown factors such as
instrumental drift, batch effects, sample work up errors, or
measurement errors. In the present data set, the residual
part will largely consist of biological variability. This is
caused by the fact that each measurement represents a
liver sample of a separately sacrificed mouse. Evidently,
no true replicates in time are available.
Simultaneous Component Analysis (SCA)
SCA [13] is an extension of Principal Component Analysis
(PCA; [14]) that can be used in the situation where the
same variables have been measured in two or more popu-
lations. Examples of such populations are groups of mice
that have been fed on different diets. Similar as with PCA,
SCA analyses data by summarizing and projecting these in
a new space. This new space is defined by so-called simul-
taneous components, which are linear combinations of
the original axis (i.e. variables) and that meet some spe-
cific mathematical demands. These demands are defined
in such a way that the first simultaneous component
describes the largest amount of variance possible. Consec-
utive simultaneous components are orthogonal to all the
previous ones and each one describes less variation than
the previous simultaneous component. Using the simul-
taneous components, it is usually possible to describe the
data more condensed than originally. This means that a
dimension reduction can be performed which facilitates a
visual inspection of the data. In a formula, SCA can be rep-
resented as follows:
where X (N × J) is the matrix of the population matrices Xi
(Ni × J); Ti (Ni × J) are the scores which are the projected
original data into the space of the loadings P (J × R); and
E (N × J) is the residual. The indices N, Ni, J, and R indicate
the total number of objects, the number of objects in pop-
ulation i, the number of variables, and the selected dimen-
sion in which the data are summarized well (R  <J),
respectively. Compared to PCA, the advantage of SCA is
that multi-population data are described in one model
with one loading matrix containing the simultaneous
components. However, if there are no constraints placed
on scores Ti, the SCA model of Equation 1 is equal to PCA
on the concatenated matrix X. Timmerman & Kiers [15]
describe some possible choices for these constraints and
the resulting consequences for the corresponding analysis.
As discussed before, a drawback of both PCA and SCA is
that the information sources in the models are con-
founded. This means that the interpretation of the models
can become problematic. A way to solve this problem is
by analysing separate data blocks that correspond to
unique and known sources of variance.
ANOVA-Simultaneous Component Analysis (ASCA)
In ASCA, the advantages of SCA and ANOVA are com-
bined [5,6]. This leads to a method in which the original
data are split into orthogonal data blocks that can be
attributed to a specific factor of interest. On these separate
data blocks, SCA can be applied to analyze them using the
concept of data reduction. The multivariate analogue to
the univariate ANOVA model (Equation 1) is:
xkcij = μj + αkj + βcj + (αβ)kcj + εkcij (3)
In this equation, the index j is added to account for all the
J variables in the data sets that are described. Thus, Equa-
tion 3 represents a series of J ANOVAs. Subsequently, all
the terms in the latter equation can be collected in matri-
ces X with dimensions (n × J), leading to Equation 4:
X = 1mT + Xk + Xc + X(kc) + Xe (4)
where 1 is a size n column vector and mT a size J row vector
containing all estimates of μj. If SCA component models
are used to approximate the information in the matrices
Xk, Xc, and Xkc, the ASCA model that corresponds to the
ANOVA model of Equation 1 is:
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The matrices Tk, Tc, T(kc) are the SCA scores of the factors
K, C, and their interaction, respectively; Pk, Pc, and P(kc) are
the corresponding loadings, while E is the residual data
that cannot be attributed to a known factor. Under the
proper constraints ASCA can be calculated very simply.
For a balanced design, it has been found that this can be
achieved by a proper centring and performing PCA on the
rearranged data blocks [5]. Because these constraints are
used in this study, in the remainder of this paper the
expression 'principal components' will be used instead of
'simultaneous components'.
ANOVA-Partial Least Squares
Similar as with ASCA, ANOVA-PLS is the combination of
variance decomposition to extract different effects and a
subsequent statistical analysis. In this case this analysis is
regression with PLS. PLS has been described extensively by
[16] and, more recently, for genomic data by [17]. It is a
data modelling technique that is used to determine the
relationship between a multivariate data set and a univar-
iate phenotype. Depending on the fact if the phenotype is
discrete (e.g. a group membership) or continuous (e.g. a
concentration), this becomes a classification or a regres-
sion analysis, respectively. In this paper, only regression is
considered. PLS is able to analyze large numbers of varia-
bles in small sample sizes by reducing the dimensionality
of the data. The dimension reduction is achieved by con-
structing latent components (PLS factors), in such a way
that these components have maximal covariance with the
outcome variable whereas the latent components them-
selves are uncorrelated. Note that the optimal number of
PLS factors is a model meta-parameter that needs to be
estimated independently from the regression perform-
ance. This is explained in the next section.
For ASCA, each data block was analysed separately by SCA
to interpret the different effects. ANOVA-PLS slightly dif-
fers in the sense that different combinations of effects are
used to determine the relation between the data types
rather than single effects. The advantage of analyzing
selected combinations of effects is that certain effects are
highlighted or excluded, compared to the total data,
which enables a specific zoom into the data. An addi-
tional statistical reason to use effect combinations instead
of single effects is that the rank of single effects is too low
to build a reliable regression model. This originates from
the ANOVA principles where effects are represented by
corresponding group means instead of individual values.
Statistical regression performance and validation
The quality of the regression models is expressed with a
Q2
CV  value after double cross-validation [18]. The Q2
parameter is defined as follows [19,20]:
In this expression, PRESS is the Prediction Error Sum of
Squares (the squared difference between the measured, yi,
and the predicted value,  , for each of the n observa-
tions), while SSY is the Sums of Squared differences
between the measured observations and their mean value
. Note that if the prediction error (PRESS) becomes
larger than the sums of squares (SSY), the Q2 value is
smaller than zero indicating a badly predicting model.
Because the data set contains 12 groups (4 time points
and 3 diets, see the experimental section), a 12-fold cross-
validation is performed where in each step one unique
group is left out. In this approach, the first cross-valida-
tion loop is used to determine the optimal meta-parame-
ter (i.e. the number of PLS factors) and the second one to
predict the performance of the model, given the selected
meta-parameter. Whereas the number of PLS factors and
the prediction performance are determined with a double
cross-validation, the final regression coefficients are deter-
mined on the total data, because here the aim is only to
find the regression coefficients that belong to the optimal
PLS model without estimating the prediction perform-
ance. The corresponding number or PLS factors is deter-
mined in a separate single cross-validation. The need for
this approach is shown by [21,22]. From the final model,
the significant variables are selected based on jack-knifing
according to [23,24]. For this reason, the RSD (Relative
Standard Deviation) of the regression coefficients was cal-
culated: the standard deviation divided by the mean. Var-
iables which have an RSD < 0.5 are considered to be
significant: their mean is larger than 2 times the standard
deviation, indicating a 95% confidence interval. Next,
with the significant and the insignificant variables, so-
called informative and uninformative models are made,
respectively [1]. These models are used to confirm the pre-
dictive power of the selected and deselected variables.
Experimental
Design of the case study
The study design is shown in Figure 1. The study involved
72 male ApoE3-Leiden mice with an age of 14 ± 2 weeks.
Three weeks before the start of the study, the mice were
fed a standard chow diet. At the start of the study, 24 mice
were switched to a High Fat Bovine diet (HF-bovine; 45
energy % bovine lard + 0.25% cholesterol), 24 62 mice to
a High Fat Palm Oil diet (HF-palm; 45 energy % palm
oil), and 24 mice stayed on the Chow diet. Of each diet
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group, 6 mice were sacrificed at time points 1 and 3 days,
and 1 and 2 weeks. As a consequence of the study design,
important factors underlying the data sets are time, diet,
their interaction: time × diet, and individual (biological)
variation.
Sample preparation and performed measurements
Liver and orbital blood was obtained from animals after a
four hour fasting period (typically from 09.00 to 13.00),
it was snap frozen in liquid nitrogen and stored at -80°C
until processing. Liver lipidomics data (lipids and free
fatty acids, FFA) were analyzed with the Lipid LC-MS [1],
and FFA LC-MS TNO platforms which can identify and
quantify about 200 different lipids and FFA. For all
detected lipids (n = 40) and FFA (n = 19), a relative con-
centration was calculated (to the internal standard which
is lipid or fatty acid class specific). The relative concentra-
tions were corrected for slight differences in liver weight.
Serum Amyloid A levels were measured by ELISA specific
for SAA (Biosource, see also [25]). Furthermore, quality
control (QC) analysis of the analytical measurements was
performed on: (1) pooled QC samples, (2) duplicate aliq-
uots of representative samples, and (3) all internal stand-
ards in all study and QC samples. Using these data, no
instrumental drift or other systematic errors could be
detected and the data quality was considered to be good.
Pre-processing and imputation
Prior to performing PLS regression analysis, the LC-MS
variables of both the fatty acids and the lipids were cen-
tred (zero mean) and scaled to unit standard deviation
(i.e. auto scaling; [26]). In this way, the individual fatty
acids and the lipids will be comparable and have similar
scales. Additionally, the SAA measurements were trans-
formed by adding the value of 1 and taking the log10 to
remove the wide range of the data. This value was added
to avoid complications when taking the logarithm of zero
or of values very close to zero because this will either be
impossible or result in artificially high (negative) values,
respectively. It was verified that this pre-treatment did not
lead to problems such as the introduction of a problem-
atic bias or the introduction of very large negative values
due to the logarithm of numbers very close to zero (data
not shown).
Due to missing samples for both the LC-MS metabolites
and SAA values, the data are unbalanced. For LC-MS, the
data consisted of 65 samples: 5 groups of 5 mice (Chow:
3d; HF-bovine: 3d and 1w; HF-palm: 1d, 1w, and 2w) and
5 groups of 6 mice. For SAA, concentrations were
obtained for 63 mice: one group consisted of two mice
(Chow, 2w), one group of 4 mice (HF-bovine: 3d), three
groups of five mice (Chow: 3d; HF-palm: 1d and 2w) and
7 groups of 6 mice. However, for both two-way ASCA and
ANOVA it is beneficial to have on groups that are equally
sized (balanced data). This ensures the estimation of inde-
pendent effects that are crucial for a proper interpretation.
Analyzing unbalanced two-way ANOVA can be done in
different ways but this is not trivial [27]. Furthermore,
special methods like REML (Restricted Maximum Likeli-
hood) might be required. However, the combination of
REML with methods for the analysis of high-dimensional
data such as SCA is a topic of ongoing research and not
available yet. Therefore, in order to deal with the imbal-
ance in ANOVA and ASCA, the groups consisting of less
than 6 mice were completed (imputation). For the LC-MS
data, imputation was performed by a random draw from
a normal distribution defined by the specific group mean
and the standard deviation. For SAA, conditional estima-
tions were imputed [28,29]: (1) a PLS model was created
The design of the study Figure 1
The design of the study. This figure shows the division of the mice into the three diet groups and the time points on which 
the measurements have been performed.
1d 3d 1w 2w
3w Run-in
Chow (n=62)
HF-palm (n=62)
45 E% palm oil
HF-bovine (n=62)
45 E% Bovine suet
0.25% cholesterol
72 male mice
(apoE3-Leiden)
Age: 14 r 2w Chow
(n=6) (n=6) (n=6) (n=6)
(n=6) (n=6) (n=6) (n=6)
(n=6) (n=6) (n=6) (n=6)BMC Bioinformatics 2009, 10:52 http://www.biomedcentral.com/1471-2105/10/52
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between all available pairs of LC-MS metabolites and SAA
values (8 PLS factors were used to ensure that both blocks
were described for at least 80%) and (2) this model was
used to predict the missing SAA values. Consequently,
each missing SAA value was replaced by a random draw
from a normal distribution defined by the PLS prediction
from step 2 as a mean and the overall PLS model residual
as a standard deviation. In an experiment where each ran-
dom draw was randomly repeated 500 times, it will be
shown that this approach consistently leads to the same
conclusions throughout the paper. According to Rubin &
Schenker [30], the strategy adopted is a so-called proper
imputation strategy assuming ignorable reasons for the
missing data. This means that imputation was performed
while reflecting the variability in the data while no sys-
tematic differences could be assumed between the missing
data within a condition. Note that the aim of this paper is
not to present a final prediction model for the study but
to show how different analysis approaches (i.e. ANOVA-
PLS versus PLS) on the same data can lead to different
results.
When applying regression analysis to determine the rela-
tionship between liver no imputed samples were used but
only those samples that were originally available for both
liver lipidomics and blood SAA (61 samples).
Software
All statistical data analyses were performed with Matlab
7.1.0, release 14 (The Mathworks, Natick, MA, USA). The
used techniques were: PLS in a double cross-validation
framework, data decomposition, ANOVA and ASCA. PLS
was performed using the PLS Toolbox 3.5.2 (Eigenvector
Research, Manson, WA, USA). Double cross-validation
was performed according to the software from [21]. Data
decomposition, ANOVA, and ASCA were performed
according to the software from [6]. The software from
these references is available at http://www.bdagroup.nl.
Results and discussion
The influence of data imputation
In this study, a conditional imputation strategy was per-
formed to balance the groups, partly relying on a random
draw of new samples. This random draw can introduce
irrelevant and uninteresting variation which is unwanted.
Therefore, in order to evaluate the influence of the ran-
dom selection, the complete imputation procedure was
repeated 500 times. The results were 500 balanced data
sets, each consisting of 72 mice with 1 SAA value (pheno-
type) and 72 lipidomics measurements (i.e. 4 time points
× 3 diets × 6 mice per group). For each data set, ASCA,
ANOVA and ANOVA-PLS models were made. The results
are box plots that show the design-related effect-size dif-
ferences together with the variation induced by the impu-
tation strategy.
In Figure 2, it is shown that the overall trend of effect sizes
for both ASCA and ANOVA is clear even though the effects
of the individual 500 realizations may vary. The Q2
CV val-
ues of Figure 3 are derived from the PLS models based on
different combinations of the ASCA and ANOVA data
blocks. Figure 3 shows a similar situation as Figure 2: the
overall trend is clear but individual effect sizes do vary.
Together, it can be concluded that the random compo-
nent of the imputation strategy does not affect the data
analysis. Therefore, one of 500 realizations was selected
for further analysis in this study. This was the realization
which was closest to the median results for the 500 ASCA
and ANOVA realizations.
From Figures 2 and 3 it follows that the residual part is a
very important component of the total variance. The
residual part most likely exists of three elements: (1) lipi-
domics and SAA measurement noise, (2) ANOVA and
ASCA modelling error, and (3) biological variation, possi-
bly as a result of epigenetic effects. However, in this case,
it is impossible to further identify and quantify these ele-
ments of the residual part because no true replicates could
be measured (each mouse was sacrificed). In addition, the
underlying factors leading to the biological variation were
not known in advance. If these factors would have been
known, they could have been treated as the other study
design factors, viz. diet and time. This would make the
unexplained residual part smaller and lead to a better
understanding of the data structure and to more statistical
power. The assumption that structured biological varia-
tion is important in the total residual part is supported by
the observation that the lipidomic and SAA measure-
ments correlate: a PLS regression model based only on the
residual part still performs reasonably well. This is not to
be expected if the residual contains only measurement
uncertainty in SAA and lipidomics measurements. There-
fore, it is likely that the residual is dominated by: (a) struc-
tured biological variation, and (b) higher order effects
both in SAA and lipidomics.
ANOVA and ASCA for explorative analysis
As described above, the steps of variance decomposition
are used to separate the total data set into blocks that can
be attributed to known effects arising from the underlying
study design. The advantages of performing regression on
the decomposed data are investigated in this paper. How-
ever, before doing so, it is very informative to investigate
the different effects using ANOVA for the univariate SAA
measurements and its multivariate counterpart, ASCA, for
LC-MS lipidomics.
Figure 4 shows the SCA results for the lipidomics data set
where the factors time, diet, and time × diet represent 13%
(p = 0.0003), 14% (p = 0.001), and 11% (p = 0.19) of the
total variance, respectively. The p-values were derived asBMC Bioinformatics 2009, 10:52 http://www.biomedcentral.com/1471-2105/10/52
Page 7 of 15
(page number not for citation purposes)
described by [31]. It is obvious that from 1d to 3d, the
largest time effect is present. Between the other time
points, only small differences can be observed. Further-
more, it can be seen that the 3 diets induce different
responses although the 2 high fat diets are more similar to
each other than to the Chow diet. Finally, because the
interaction effect is insignificant, no conclusion can be
drawn from that.
Figure 5 shows the ANOVA results on the univariate SAA
measurements. In this model, only the diet effect (48%) is
significant (p = 9·10-11). The diet effect in the SAA meas-
urements shows a similar trend as the diet effect in the lip-
idomics measurements, even though the latter effect is
much smaller. The other effects (time: 4%; p = 0.13 and
time × diet: 6.5%; p = 0.17) show a different behaviour for
SAA than for the LC-MS metabolites. In addition, these
effects have high p-values indicating that they do not
reach significance in terms of the traditional cut-offs (α =
0.05 or α = 0.1).
When comparing the ASCA and ANOVA results, the diet
effect shows a very similar behavior between the two data
sets, and it is the only effect that is significant for both data
types. The other effects display different behavior and are
not significant for both data types simultaneously.
Regression analysis with PLS and ANOVA-PLS
The main goal of this study was to investigate the relation-
ship between liver lipid metabolites and plasma inflam-
mation markers by exploiting the underlying study
structure in a multivariate analysis. Table 1 shows the
Box plots of ASCA and ANOVA results Figure 2
Box plots of ASCA and ANOVA results. Box plots are shown for the explained variances of the ASCA (upper plot) and 
ANOVA effects (lower plot) for 500 random realizations of the imputation strategy.
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regression results on the basis of different combinations
of data blocks where each data block contains data for one
effect. In Table 2, the correlation coefficients are shown
for the regression coefficients from the different models.
From these tables it can be concluded that different mod-
els are generated when making models on basis of parts of
the data. These differences are evident from differences in
prediction quality (Q2
CV) and from the correlations
between the models. From the correlations, two groups of
models appear: (1) the highly correlated models 1, 4, 6
and 8, all containing the diet effect; and (2) the highly cor-
related models 2, 3, 5 and 7, all without the diet effect.
Note that models 1 (all data) and 2 (using only the resid-
ual part) are not strongly correlated, indicating that the
effects of time, diet, and residual part have an important
role. Among these effects, the diet effect is the most
important one because it leads to a separation of the mod-
els into two groups each containing models that correlate
well with each other: the ones with and without this effect.
A high correlation can be observed from the correlations
between model 2 (only the residual part) and models 3
(residual and time) and 5 (residual and interaction).
These models are strongly correlated (R2 ≥ 0.95) which
implies that adding time and/or interaction to this model
does not result in different relations. However, the corre-
lation between these models and model 4 is small (R2 ≤
0.38) which indicates that the modelled relation changes
Box plots of the regression results Figure 3
Box plots of the regression results. Box plots for the Q2
CV values between the predicted SAA values and the measured 
ones. Different combinations of the effects are shown at the x-axis. The abbreviations R, T, D, and I stand for: Residual, Time, 
Diet, and Interaction, respectively.
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due to the diet effect. This conclusion is supported by the
ASCA and ANOVA results: the diet effect is similar in
structure and significant for both the lipidomics and SAA
measurements. It is important to note that even if the
modelled relations strongly correlate, this does not neces-
sarily imply that the predictions by the models are similar.
For example, models 1 (all data) and model 4 (residual
and diet) highly correlate (R2 = 0.79), but model 4 per-
forms better (Q2
CV = 0.52 versus Q2
CV = 0.63). A similar
conclusion can be deduced from comparing models 2
(residual) and 3 (residual and interaction): the correlation
is high (R2 = 0.95) but the latter model is superior (Q2
CV =
0.44 versus Q2
CV = 0.56).
Taken together, the best performing models are obtained
by removing the interaction effect while maintaining the
diet effect. Including or removing the time effect does not
affect the prediction performance. Therefore, the relation
between liver lipidomics and SAA is determined mostly by
the diet. This can also be seen from the ANOVA and ASCA
results. Removing the interaction might be beneficial for
the PLS prediction because this is a higher order effect. In
contrast to linear relations, higher order effects cannot be
modelled well by PLS. Also, our findings clearly demon-
strate that the residual part contains an important fraction
of the variation that is required to find a good relationship
between the lipidomics and the SAA data. It is very likely
that this variation contains structured biological variation
and/or higher order effects.
For comparison, also univariate correlations have been
calculated for all individual metabolites and the SAA
ASCA results of the lipidomics data Figure 4
ASCA results of the lipidomics data. The ASCA results for the factors time (top figure), diet (middle figure), and their 
interaction (bottom figure) in ApoE3Leiden mice liver lipidomics data. In the interaction model, the grey line represents mice 
on Chow diet, the black line represents mice on HF-bovine diet, and the dotted line represents mice on HF-palm diet. For all 
effects, the numbers of PCs have been selected to represent at least 80% of the variance of one factor.
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ANOVA results of the SAA data Figure 5
ANOVA results of the SAA data. The SAA ANOVA results are shown for the factors time (top), diet (middle), and their 
interaction (bottom). In the interaction model, the grey line represents mice on Chow diet; the black line represents mice on 
HF-palm diet; and the dotted line represents mice on HF-bovine diet. The corresponding p-values are 0.13, 9·10-11, and 0.17, 
respectively.
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Table 1: Summary of the regression models
Model nr Effects included for both the metabolites and for SAA Q2
CV PLS factors Metabolites: Used variation (%) SAA: Used variation (%)
1 All data 0.52 6 100 100
2 Residual 0.44 4 63 41
3 Residual, Time 0.51 4 75 45
4 Residual, Diet 0.63 5 76 89
5 Residual, Interaction 0.56 4 74 48
6 Residual, Time, Diet 0.63 6 89 93
7 Residual, Time, Interaction 0.56 5 86 52
8 Residual, Diet, Interaction 0.58 6 87 96
The Q2
CV values are presented for the predicted SAA values and the measured ones (n = 61). The prediction of the SAA values was done with 
double 12-fold cross-validation. The Q2
CV value represents the percentage of variation of SAA that is explained by the variation in metabolites.BMC Bioinformatics 2009, 10:52 http://www.biomedcentral.com/1471-2105/10/52
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measurements, taking into account the design structure in
the same way as for the multivariate analysis. The overall
most significant correlation (R2) was 0.47 (p = 1.13·10-9).
This indicates that the frequently used one-metabolite-at-
a-time approach (i.e. univariate analysis) in this case finds
weaker relations between metabolites and SAA compared
to a multivariate approach in which the correlations
between the separate metabolites are taken into account.
Therefore, univariate correlations are not taken into
account further.
In the remainder of this paper, only two models will be
compared: model 4 (residual and diet) and the original
model (model 1). This comparison will demonstrate the
differences when interpreting a model that is dedicated
towards a specific effect and a model containing all effects.
It will be shown that the former model is more reliable
and leads to a better interpretation than the original
model.
For the two models, the performances and the final regres-
sion coefficients are shown by Figures 6 and 7, respec-
tively. Together with Table 2 it is shown that the similarity
is very alike between the two models. However, some dif-
ferences exist. The confidence intervals of model 4 are
smaller than those of model 1 (overall standard deviation
of 0.048 versus 0.076). Furthermore, model 1 leads to 8
significant metabolites (metabolites with RSD smaller
than 50%) while model 4 leads to 15 significant metabo-
lites. In total, 16 unique metabolites were found signifi-
cant in either of the two models of which the models have
7 in common. In addition, the following metabolites were
never found significant for any of the two models: 14 of
19 FFAs (F16:0, F16:1, F16:2, F18:0, F18:2, F18:3, F18:4,
F20:0, F20:1, F20:2, F20:3, F20:4, F22:3, F22:4), 4 of 6
LPCs (L16:0, L18:0, L18:2, L18:3), 6 of 10 PhCs (P32:0,
P32:1, P34:2, P36:3, P36:4, P38:4) and 19 of 24 TGs
(T44:0, T44:1, T46:0, T46:1, T48:0, T48:1, T48:2, T48:3,
T50:5, T50:2, T50:4, T52:2, T52:3, T52:4, T54:2, T54:3,
T54:4, T54:5, T56:5). The differences between the signifi-
cant and insignificant metabolites were not caused by triv-
ialities such as molecular chemical differences as the
molecule sizes or the number of saturated bindings. Table
3 shows the significant metabolites for the best model
(model 4) and the overlap with model 1.
Finally, for each of the two models, two new models were
made to investigate the robustness of the significant
metabolites [1]. For the first new model only the signifi-
cant metabolites are used (leading to an informative
model), while for the other new model only the insignifi-
cant metabolites are used (an uninformative model). For
the informative and uninformative models based on
model 1, the performances decreased to Q2CV = 0.36 and
Q2CV = 0.34, respectively. For model 4, the informative
model performed similar to the original model (Q2CV =
0.65) while the performance of the uninformative model
decreased (Q2CV = 0.11). This means that the significant
metabolites found from model 4 are robust while the
insignificant ones are indeed uninformative. For model 1,
all metabolites are needed to enable a reasonable model,
which means that this model is not suitable to gain inter-
pretation from the models because the reliability of differ-
ences between significant and insignificant metabolites is
low.
Collectively, our analyses demonstrate that a regression
analysis can benefit from data decomposition on basis of
the study design which is used to select specific sources of
variation (effects) on which a model is built. On the one
hand, this can provide more insight into how different
effects relate to a phenotype. On the other hand, the
regression analysis can improve by better statistics (pre-
diction quality and reliability of the models). It also
appears that due to the improved model reliability, more
significant variables can be found (more statistical power)
which potentially leads to a better understanding of the
final model.
Biological interpretation
After establishing a statistically validated model, the next
step is to interpret the model and its important metabo-
lites from a biological perspective. If parts of the model
are confirmed by existing knowledge, it becomes more
likely that the unconfirmed parts might indicate useful
leads that deserve further investigation. However, the
interpretation of the most important metabolites from
Table 3 is limited by the identifiers that were used. These
identifiers are based on the molecular element composi-
tion which was again based on the exact mass. Most of
these identifiers require additional analysis to uniquely
determine the corresponding metabolite name. However,
some of the identifiers did allow a unique association
with a metabolite name and consecutively lead to a plau-
sible biological interpretation.
Table 2: Correlations between the regression models
M o d e l  n r 1234567 8
11
20 . 3 8 1
3 0.37 0.97 1
4 0.79 0.38 0.33 1
5 0.34 0.95 0.92 0.30 1
6 0.87 0.34 0.35 0.85 0.25 1
7 0.37 0.91 0.94 0.26 0.93 0.28 1
8 0.94 0.40 0.35 0.85 0.38 0.79 0.36 1
The squared correlations are shown for the regression coefficients of 
the different models. All correlations have a p-value < 0.001.BMC Bioinformatics 2009, 10:52 http://www.biomedcentral.com/1471-2105/10/52
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F20:5 and F22:6 are known to be unique identifiers for
omega-3 fatty acid EPA and omega-3 fatty acid DHA,
respectively. Moreover, it is known that F22:5 and F24:5
are also omega-3 fatty acids. Table 3 and Figure 7 show
that these fatty acids are negatively correlated with the
used phenotype: the inflammation marker SAA. This
again corresponds well with the fact that omega-3 fatty
acids are known to be anti-inflammatory [32]. Note that,
omega-3 fatty acids EPA and DHA (F20:5 and F22:6) are
only found in model 4: the model that finds the best and
most reliable relation with the phenotype.
Conclusion
Regression analysis is a statistical tool that can uncover
relationships between two types of data sets. Once reliable
regression models are derived, regression coefficients can
be used to derive knowledge regarding the two types of
data. However, when studying complex biological sys-
tems, the data comply with a study design. The goal of a
study design is to generate relevant information while
diminishing the unwanted variation. Knowledge about
the study design can be used to decompose the total data
into data blocks that are associated with specific effects.
Regression results of models 1 and 4 Figure 6
Regression results of models 1 and 4. The PLS prediction results are shown for model 1 (Q2
CV = 0.52) and model 4 (Q2
CV 
= 0.63), respectively. The measured SAA values are plotted against the predicted one. The dotted diagonal line indicates the 
ideal result with a perfect fit. The diets Chow, HF-bovine, and HF-palm are abbreviated by C, B, and P, respectively.
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Subsequent analysis can benefit from this decomposition
if these are applied on selected combinations of effects. In
this way more focus can be put on specific blocks and dis-
turbances can be minimized.
This paper shows that combining ANOVA with PLS regres-
sion leads to models that differ in structure and statistical
quality. The regression coefficients of these different mod-
els can then be used to study specific effect related rela-
tions between two types of data. Additionally, removing
specific effects from the relation can lead to statistical
models that are better, more robust and with more relia-
ble important variables. The biological interpretation
shows that reliability of the most important variables is
important to avoid missing useful information. This is
especially the case for nutritional studies where subtle
effects are expected.
A potential drawback of this approach is that unbalanced
multi-way ANOVA (and ASCA) models are difficult to
interpret. In this paper, this problem was solved by a con-
ditional imputation strategy. It was shown that this strat-
egy leads to consistent overall conclusions and therefore
did not affect the analysis.
It was also shown that the often used univariate approach
(finding correlations between single variables and the
phenotype) did not lead to models that were competitive
Regression coefficients of models 1 and 4 Figure 7
Regression coefficients of models 1 and 4. The regression coefficients are shown for models 1 and 4, respectively. The 
bars show the mean regression coefficients ± 2 × standard deviation.
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to multivariate regression. The ultimate best univariate
model performed much worse than the multivariate one,
even though the analyses were performed on the same
selection of data sets.
Importantly, the presented approach of PLS regression on
selected data blocks is not limited to only metabolomics
data. It is applicable to all types of data with a known
underlying structure. Moreover, it can be used in studies
where one of the data sets is continuous (such as a con-
centration), for data that contain a subdivision in groups
(classification problems) and for explorative analysis of
the data (e.g. ASCA).
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